Leggett Thomas (CIK 1774690) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell STOK (1,274 shares), Sell STOK (922 shares), Sell STOK (2,173 shares), Sell STOK (172 shares), Sell STOK (37 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | Sell | 1,274 | $41,711 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | Sell | 922 | $30,776 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | Sell | 2,173 | $67,971 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | Sell | 172 | $5,468 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | Sell | 37 | $1,215 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | Buy | 14,750 | $0 |
Source: SEC Form 4 filings · as of 2026-03-19